Download Free Medical Neuromuscular Diseases PowerPoint Presentation

Neuromuscular Diseases PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "Neuromuscular Diseases” by Radim Mazanec, MD, PhD.

This medical PowerPoint presentation is about neuromuscular diseases, a group of disorders that affect the nerves that control voluntary muscles and the muscles themselves. These conditions can cause weakness, atrophy, cramping, and loss of coordination in the muscles.

Some common examples of neuromuscular diseases include:

Muscular dystrophy: a group of genetic diseases that cause progressive muscle weakness and wasting.
Myasthenia gravis: a chronic autoimmune disease that causes muscle weakness and fatigue.
Amyotrophic lateral sclerosis (ALS): a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and atrophy.
Multiple sclerosis (MS): a chronic autoimmune disease that affects the central nervous system, causing a wide range of symptoms, including muscle weakness and spasticity.
Parkinsons disease: a progressive neurological disorder that affects movement and muscle control.
Charcot-Marie-Tooth disease: a group of genetic disorders that affect the peripheral nerves, causing muscle weakness and atrophy.

Treatment for neuromuscular diseases varies depending on the specific condition and the severity of the symptoms. Some treatments may include medication, physical therapy, surgery, or assistive devices such as braces or wheelchairs.

Tags : neuromuscular diseases, Muscular dystrophy, Myasthenia gravis, Amyotrophic lateral sclerosis, Multiple sclerosis, chronic autoimmune disease, Parkinsons disease, Charcot-Marie-Tooth disease, Neurology, Neurology PowerPoint presentation

Published on : Jun 20, 2023 | Views : 604 | Downloads : 2

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Neuromuscular Diseases Radim Mazanec, MD, Ph.D Department of Neurology
Slide 2-

Disorders of the Motor Unit Peripheral nerve disorders Motor neuron disease Neuromuscular junction disease Muscle disease
Slide 3-

Peripheral Nerve Disorders Mononeuropathy Pattern of weakness and sensory loss conforms to the distribution of a single nerve Carpal tunnel syndrome Peroneal palsy at the fibular head Mononeuritis multiplex Multiple nerves affected in a random pattern Acute onset, frequently painful Diabetes mellitus, vasculitis Polyneuropathy (peripheral neuropathy) Distal, symmetric
Slide 4-

Polyneuropathies Can affect different types of fibers Autonomic Motor Sensory Large well myelinated Small poorly myelinated or unmyelinated
Slide 5-

Symptoms of a Polyneuropathy Sensory symptoms Start in feet, move proximally Hand sxs appear when LE sxs up to knees Positive Pins and needles Tingling Burning Negative Numbness Deadness “Like I’m walking with thick socks on”
Slide 6-

Exams of peripheral neuropathy Sensory impairment akroparesthesias or tactile hypestesias glove or sock distribution Vibration disturbances pallhypestesia distally (tuning fork C 128 Hz)
Slide 7-

Bed side tests tactile vibration thermal myotatic reflexes
Slide 8-

Clinical features of polyneuropaties Weaknes of LL Atrophies of distal muscles Deformities pes cavus Walk on heels Normal muscles strenght at proximal muscles
Slide 9-

Diabetic feet and ulcerations Amputation CR 8 000/y Germany 30 000/y
Slide 10-

Foot deformity in hereditary neuropathy (CMT disease) pes cavus
Slide 11-

ppt slide no 11 content not found
Slide 12-

Classification of Polyneuropathies By types of fibers involved Pure sensory Sensory motor Pure motor Autonomic By pathology Demyelinating Axonal Mixed By tempo Acute Subacute Chronic
Slide 13-

Acute Polyneuropathies Guillain Barre Syndrome Porphyria Neuropathy, psychiatric disorder, unexplained GI complaints Toxins Glue sniffing (n-hexane) Arsenic
Slide 14-

Guillain-Barré Syndrom G Guillain JA Barré A.Strohl Bulletin de Societe des Medicines Hopitals de Paris,1916;40:1462. Guillain Barré syndrom from 1927
Slide 15-

Guillain Barre Syndrome Most common cause of rapidly progressive weakness Demyelinating neuropathy Ascending weakness which may include cranial neuropathies Exam reveals symmetric weakness with areflexia and large fiber sensory loss Bowel and bladder usually preserved
Slide 16-

Guillain Barre Syndrome, cont Respiratory failure can be precipitous Other causes of morbidity and mortality Autonomic instability DVT Infection Immune mediated, may be post infectious Treatment Plasma exchange Intravenous immunoglobulin
Slide 17-

Subacute Polyneuropathies Vasculitis Can be isolated to peripheral nerves or part of a more systemic process Paraneoplastic May be presenting symptom of the cancer Chronic inflammatory demyelinating polyneuropathy With or without a gammopathy Toxins Drug
Slide 18-

Chronic Polyneuropathies Metabolic Diabetes mellitus Chronic renal failure Chronic liver failure Thyroid disease Nutritional B12 deficiency Infections HIV Leprosy Inherited – Charcot Marie Tooth disease since 1886
Slide 19-

Evaluation of a Polyneuropathy Lab work Nerve conduction study/electromyography Distinguishes between axonal and demyelinating Helps ascertain severity Nerve biopsy Frequently non-diagnostic Can establish the dx in certain disorders, such as vasculitis and amyloidosis
Slide 20-

Electromyographyfunctional diagnostic method Conduction studies Needle EMG Test of NM transmision
Slide 21-

Conduction study of peroneal n. Conduction study of sural n.
Slide 22-

Needle electromyography Concentric electrode
Slide 23-

Myogenic lesion 1 mV
Slide 24-

Chronic neurogenic lesion 8 mV
Slide 25-

Disorders of the Motor Unit Peripheral nerve disorders Motor neuron disease Neuromuscular junction disease Muscle disease
Slide 26-

Motor Neuron Disease Diseases that can involve Betz cells of the motor cortex, the lower CN motor nuclei, the CST, and/or the anterior horn cells Amyotrophic Lateral Sclerosis (ALS) – 80% Progressive bulbar palsy – 10% Progressive muscular atrophy, spinal muscular atrophy – 8% Primary lateral sclerosis – 2%
Slide 27-

Dion PA et al.Genetics of motor neuron disorders:new insight into patogenic mechanism.Nature Genetics 2009,10:769-782.
Slide 28-

Epidemiology of ALS ALS (Lou Gehrig´s disease) Prevalence - 4-6 : 100 000 Incidence - 0.5-3 : 100 000 90-95% sporadic forms of ALS (SALS) No family history 5-10% familial forms of ALS (FALS)
Slide 29-

Classical ALS First symptoms : limbs 75% bulbar sy 25% Upper limbs - 41% Lower limbs - 34%
Slide 30-

ALS – clinical features Loss of motor neurons in the cortex, brainstem and spinal cord Mix of upper motor neuron and lower motor neuron findings Weakness, atrophy, fasciculations Slurred speech, difficulty swallowing, shortness of breath Can start in any extremity or the bulbar musculature Relentlessly progressive
Slide 31-

ALS - prognosis 50 % dead in 3 years, 80% dead in 5 years, 5 - 10% live more than 10 years Death usually from respiratory failure
Slide 32-

Diagnostic algorhitm in ALS Clinical symptoms UMN + LMN Electromyography MRI brain + C spinal cord Liquor evaluation (infection) Sometimes paraneoplastic exams
Slide 33-

ppt slide no 33 content not found
Slide 34-

ppt slide no 34 content not found
Slide 35-

ppt slide no 35 content not found
Slide 36-

ppt slide no 36 content not found
Slide 37-

Treatment of ALS Causative treatment is not available Neuroprotective treatment riluzol - inhibitor of glutamate acid antioxidans – koenzym Q10 + vitamin E Experimental and clinical studies on more than 200 moleculs – IGF-1, minocycline, creatine ethyl ester, tamoxifen…
Slide 38-

Treatment of ALS Symptomatic-paliative treatment – most important today Mobility – -sticks, wheelchair, multifunctional bed Nutrition – PEG + Nutrizone Communication – tables, books,vocal communicators, PC Anxiety and depresion – antideperesive drugs, psychotherapy Respiration – non-invasive BiPAP or invasive Whole family care
Slide 39-

Treatment of ALS Stem cell therapy – clinical studies are ongoing, including University Hospital Motol (2012-2014 – 30 ALS pts) 10 mio per kg Systemic aplication i.v. Intrathecal aplication Combination i.v. + i.th. Intraspinal aplication – L spinal cord, later C spinal cord Up to date – no EBM data, but in next year – several studies will be finished